Vasopeptidase inhibition: Cardiovascular therapy for the new millennium?

Journal of Human Hypertension

Volumn 14, Issue 9, 2000, Pages 537-539

  Walters, M ^a   Reid, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular therapy; Vasopeptidase inhibition

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; MEMBRANE METALLOENDOPEPTIDASE; OMAPATRILAT; PEPTIDE HYDROLASE INHIBITOR; UNCLASSIFIED DRUG; VASOPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE ACTIVITY; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; COUGHING; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; EXPERIMENTAL MODEL; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; NONHUMAN; NOTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RESISTANCE; VASODILATATION;

EID: 0033812754     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001101     Document Type: Note

References (11)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
2. Inadequate management of high blood pressure in a hypertensive population
3. Neutral endopeptidase inhibitors and combined inhibitors of neutral endopeptidase and angiotensin converting enzyme
4. Bradykinin-mediated effects of ACE inhibition
5. Dual metalloproteinase inhibitors. Mercaptoacetyl-based fused heterocyclic dipeptide minetics as inhibitors of angiotensin converting enzyme and neutral endopeptidase
6. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase in rats with hypertension
7. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin converting enzyme BMS-182657 in experimental hypertension and heart failure
8. Dual metalloproteinase inhibition during the development of left ventricular failure: Effects on LV and myocyte function and geometry
9. Supine mean arterial blood pressure lowering and oral tolerance of BMS-186716, a new dual metalloproteinase inhibitor of angiotensin converting enzyme and neutral endopeptidase in healthy male subjects
10. Effects of BMS-1867, a new dual metalloproteinase inhibitor on pharmacodynamic markers of angiotensin converting enzyme and neutral endopeptidase activity in healthy men
11. Monotherapy treatment success rate of omapatrilat compared with lisinopril and amlodipine in mild to moderate hypertension